{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:39:51Z","timestamp":1792683591503,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijid.2026.109103","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:47:14Z","timestamp":1788565634000},"page":"109103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mixing versus matching booster vaccines: Longitudinal humoral immune kinetics against Omicron in a Malaysian cohort"],"prefix":"10.1016","volume":"172","author":[{"given":"Ashwathy Varadarajan","family":"Thundakattil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuvel","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsubhra","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Htoo Htoo Kyaw","family":"Soe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Patrick","family":"Arjunan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumandeep Kaur","family":"Chahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debban A\/L","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ng Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soh Pei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaayshree A\/P","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhytha A\/P","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila Nu Nu","family":"Htay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9316-8819","authenticated-orcid":false,"given":"Sabyasachi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109103_bib0001","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/vaccines10050696","article-title":"The effect of waning on antibody levels and memory B cell recall following SARS-CoV-2 infection or vaccination","volume":"10","author":"Forgacs","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2026.109103_bib0002","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-07895-6","article-title":"Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia","volume":"15","author":"Thundakattil","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.109103_bib0003","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1002\/jmv.27927","article-title":"Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: a comparative sequence and structural-based computational assessment","volume":"94","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2026.109103_bib0004","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/cid\/ciac435","volume":"75","author":"Lim","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.109103_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103904","article-title":"Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong","volume":"77","author":"Peng","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijid.2026.109103_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12916-024-03471-3","article-title":"Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"22","author":"Asante","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0007","unstructured":"Ministry of Health Malaysia. Latest COVID-19 Vaccination Policy, https:\/\/mysejahtera.moh.gov.my\/en\/covid-19\/latest-malaysia-covid-19-vaccination-policy; 2022 [accessed on 15th December 2022]."},{"key":"10.1016\/j.ijid.2026.109103_bib0008","unstructured":"Malaysian Society of Infectious Diseases & Chemotherapy. Upcoming vaccines. COVID-19, https:\/\/adultimmunisation.msidc.my\/covid-19\/; 2026 [accessed on 29th June 2026]."},{"key":"10.1016\/j.ijid.2026.109103_bib0009","article-title":"Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape","volume":"19","author":"Das","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ijid.2026.109103_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127601","article-title":"Immune responses to a heterologous booster with mRNA based COVID-19 vaccine after priming with an inactivated Newcastle disease virus recombinant vaccine expressing the SARS-CoV-2 spike protein (NDV-HXP-S)","volume":"62","author":"Luvira","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.109103_bib0011","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41467-023-37128-1","article-title":"Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain","volume":"14","author":"Takano","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.109103_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19776-3","article-title":"Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia","volume":"12","author":"Tan","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.109103_bib0013","unstructured":"Clinical guidelines on Covid-19 vaccination in Malaysia 4 edition, https:\/\/covid-19.moh.gov.my\/garis-panduan\/garis-panduan-kkm\/ANNEX_48_CLINICAL_GUIDELINES_FOR_COVID_IN_MALAYSIA_4th_EDITION_19102021_FINALE.pdf; 2026 [accessed on 18th May 2022]."},{"key":"10.1016\/j.ijid.2026.109103_bib0014","unstructured":"Government of Malaysia. My Sejahtera application, https:\/\/mysejahtera.moh.gov.my\/ms\/; 2026 [accessed on 16th January 2022]."},{"key":"10.1016\/j.ijid.2026.109103_bib0015","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1038\/s41598-022-06977-z","article-title":"Multiplex real-time RT-PCR method for the diagnosis of SARS-CoV-2 by targeting viral N, RdRP and human RP genes","volume":"12","author":"Tombuloglu","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.109103_bib0016","unstructured":"Reuters. Malaysia makes COVID-19 vaccinations compulsory for government employees, https:\/\/www.reuters.com\/world\/asia-pacific\/malaysia-makes-covid-19-vaccinations-compulsory-government-employees-2021-09-30\/; 2021 [accessed on 30th September 2021]."},{"key":"10.1016\/j.ijid.2026.109103_bib0017","unstructured":"Siemens Healthcare Diagnositic Inc. Understanding SARS-CoV-2 IgG immunity thresholds and the process of standardization. https:\/\/cdn0.scrvt.com\/39b415fb07de4d9656c7b516d8e2d907\/b2406e708b287c5\/506564e9207f\/Understanding-SARS-CoV-2-IgG-Immunity-Thresholds-and-the-Process-of-Standardization.pdf; 2021 [accessed on 2nd November 2021]."},{"key":"10.1016\/j.ijid.2026.109103_bib0018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","article-title":"mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant","volume":"185","author":"Garcia-Beltran","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2026.109103_bib0019","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41392-022-01062-3","article-title":"Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ijid.2026.109103_bib0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2026.109103_bib0021","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2026.109103_bib0022","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(21)00634-6","article-title":"Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform","volume":"397","author":"Mathur","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.109103_bib0023","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMc2113468","article-title":"SARS-CoV-2 neutralization with BNT162b2 vaccine Dose 3","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00284-024-03689-7","article-title":"Homologous and heterologous Covid-19 booster vaccinations against SARS-CoV-2 infection in the elderly","volume":"81","author":"Acer","year":"2024","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijid.2026.109103_bib0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0026","article-title":"Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study","volume":"10","author":"Naaber","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ijid.2026.109103_bib0027","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0140-6736(21)02717-3","article-title":"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial","volume":"398","author":"Munro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.109103_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100334","article-title":"Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination","volume":"14","author":"Terbsiri","year":"2023","journal-title":"Vaccine X"},{"key":"10.1016\/j.ijid.2026.109103_bib0029","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMoa2116414","article-title":"Homologous and heterologous Covid-19 booster vaccinations","volume":"386","author":"Atmar","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0030","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41591-021-01449-9","article-title":"Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19\/BNT162b2 vaccination","volume":"27","author":"Barros-Martins","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0031","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.109103_bib0032","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/jmv.27688","article-title":"Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: a systematic review","volume":"94","author":"Notarte","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2026.109103_bib0033","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/vaccines10020160","article-title":"Antibody response of combination of BNT162b2 and CoronaVac platforms of COVID-19 vaccines against Omicron variant","volume":"10","author":"Khong","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijid.2026.109103_bib0034","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/22221751.2022.2072773","article-title":"Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection","volume":"11","author":"Suah","year":"2022","journal-title":"Emerg Microbes Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226007381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:49:42Z","timestamp":1792680582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226007381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":34,"alternative-id":["S1201971226007381"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109103","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mixing versus matching booster vaccines: Longitudinal humoral immune kinetics against Omicron in a Malaysian cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109103"}}